MESO

Mesoblast Ltd

Phase 3 AI-extracted

Rexlemestrocel-L

Chronic low back pain

Countdown

358days

Phase 3 readout · ~ Jun 30, 2027 estimated

What's at stake Phase 3 trial results for Rexlemestrocel-L in Chronic low back pain are due ~ Jun 30, 2027. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 6-K verified 13h ago

“Top-line results are expected in mid-CY2027 after the last randomized patient has completed follow-up.”

Add to calendar Post on X Reddit

Provenance